We present a search for a Higgs boson decaying to two W bosons in pp collisions at √ s = 1.96TeV center-of-mass energy. The data sample corresponds to an integrated luminosity of 3.0 fb −1 collected with the CDF II detector. We find no evidence for production of a Higgs boson with mass between 110 and 200 GeV/c 2 , and determine upper limits on the production cross section. For the mass of 160 GeV/c 2 , where the analysis is most sensitive, the observed (expected) limit is 0.7 pb (0.9 pb) at 95% Bayesian credibility level which is 1.7 (2.2) times the standard model cross section.
We measure the time dependence of the ratio of decay rates for the rare decay D{0}-->K{+}pi{-} to the Cabibbo-favored decay D{0}-->K{-}pi;{+}. A signal of 12.7x10;{3} D{0}-->K{+}pi{-} decays was obtained using the Collider Detector at Fermilab II detector at the Fermilab Tevatron with an integrated luminosity of 1.5 fb;{-1}. We measure the D0-D[over ]{0} mixing parameters (R_{D},y{'},x{'2}), and find that the data are inconsistent with the no-mixing hypothesis with a probability equivalent to 3.8 Gaussian standard deviations.
We present a new measurement of the inclusive forward-backward tt production asymmetry and its rapidity and mass dependence. The measurements are performed with data corresponding to an integrated luminosity of 5.3 fb −1 of pp collisions at √ s = 1.96 TeV, recorded with the CDF II Detector at the Fermilab Tevatron. Significant inclusive asymmetries are observed in both the laboratory frame and the tt rest frame, and in both cases are found to be consistent with CP conservation under interchange of t andt. In the tt rest frame, the asymmetry is observed to increase with the tt rapidity difference, ∆y, and with the invariant mass M tt of the tt system. Fully corrected parton-level asymmetries are derived in two regions of each variable, and the asymmetry is found to be most significant at large ∆y and M tt . For M tt ≥ 450 GeV/c 2 , the parton-level asymmetry in the tt rest frame is A tt = 0.475 ± 0.114 compared to a next-to-leading order QCD prediction of 0.088 ± 0.013.
We report the first measurements of inclusive W and Z boson cross sections times the corresponding leptonic branching ratios for pp collisions at √ s = 1.96 TeV based on the decays of the W and Z bosons into electrons and muons. The data were recorded with the CDF II detector at the Fermilab
4Tevatron and correspond to an integrated luminosity of 72.0 ± 4.3 pb −1 . We test e-µ lepton universality in W decays by measuring the ratio of the W → µν to W → eν cross sections and determine a value of 0.991 ± 0.004(stat.) ± 0.011(syst.) for the ratio of W −ℓ−ν couplings (gµ/ge). Since there is no sign of non-universality, we combine our cross section measurements in the different lepton decay modes and obtain σW ×Br(pp → W → ℓν) = 2.749 ± 0.010(stat.) ± 0.053(syst.) ± 0.165(lum.) nb and σ γ * /Z × Br(pp → γ * /Z → ℓℓ) = 254.9 ± 3.3(stat.) ± 4.6(syst.) ± 15.2(lum.) pb for dilepton pairs in the mass range between 66 GeV/c 2 and 116 GeV/c 2 . We compute the ratio R of the W → ℓν to Z → ℓℓ cross sections taking all correlations among channels into account and obtain R = 10.84 ± 0.15(stat.) ± 0.14(syst.) including a correction for the virtual photon exchange component in our measured γ * /Z → ℓℓ cross section. Based on the measured value of R, we extract values for the W leptonic branching ratio, Br(W → ℓν) = 0.1082 ± 0.0022; the total width of the W boson, Γ(W ) = 2092 ± 42 MeV; and the ratio of W and Z boson total widths, Γ(W )/Γ(Z) = 0.838 ± 0.017. In addition, we use our extracted value of Γ(W ) whose value depends on various electroweak parameters and certain CKM matrix elements to constrain the Vcs CKM matrix element, |Vcs| = 0.976± 0.030.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.